Skip to content
  • Tuesday, 27 October 2026
  • 6:35 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • FDA Approves Asahi Kasei Therapeutics Hovilpri for Refractory Mucocutaneous Herpes Simplex Virus in Immunocompromised Adults
Pharmaceutical R&D

FDA Approves Asahi Kasei Therapeutics Hovilpri for Refractory Mucocutaneous Herpes Simplex Virus in Immunocompromised Adults

Teuku Ryan Oct 13, 2026 0

The United States Food and Drug Administration (FDA) has granted formal marketing approval for Hovilpri (pritelivir) 100mg tablets, developed by…

Read More
Biotech & Genetic Research

Groundbreaking Discovery at University of Gothenburg Identifies Dual-Function Protein as Key Target for Genital Herpes Vaccine Development

Jia Lissa Jul 20, 2026 0

Researchers at the University of Gothenburg in Sweden have announced a significant breakthrough in the quest for a vaccine against…

Read More
Ancient Brainstem Circuit Identified as Key Driver of Selective Attention and Potential Link to ADHDDirect Observation of Bulk Oxygen Spillover in Rutile Titanium Dioxide Catalysts Unveils New Three Dimensional Pathways for Chemical ReactionsBreakthrough Research Unveils How Gene Fusion Condensates Drive Rare Kidney Cancer Progression and Potential Treatment PathwaysCornell University Scientists Identify Novel Pathway for Safe and Reversible Nonhormonal Male Contraception Through Meiotic Inhibition
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic ProportionsMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric Growth
Merck and Moderna’s cancer vaccine is customized for each patient’s tumorAn Unbiased Look at Google Gemini Omni: Features, Costs, and Market ComparisonESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial CancerLight-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Merck and Moderna’s cancer vaccine is customized for each patient’s tumor
Lana Keisha Oct 27, 2026
Data Science & Bioinformatics
An Unbiased Look at Google Gemini Omni: Features, Costs, and Market Comparison
Evan Lee Salim Oct 27, 2026
Pharmaceutical R&D
ESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial Cancer
Teuku Ryan Oct 27, 2026
Advanced Materials Science
Light-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
Nila Kartika Wati Oct 27, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ